Nuveen Asset Management, LLC Terns Pharmaceuticals, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 2,633,918 shares of TERN stock, worth $17.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,633,918
Previous 2,016,909
30.59%
Holding current value
$17.2 Million
Previous $16.8 Million
12.63%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TERN
# of Institutions
136Shares Held
84.3MCall Options Held
185KPut Options Held
89.5K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$53.3 Million2.36% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$49.4 Million1.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$48.9 Million0.99% of portfolio
-
Morgan Stanley New York, NY7.25MShares$47.4 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$45 Million5.45% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $246M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...